Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
-
* Corresponding author: Sandra E Dunn sedunn@interchange.ubc.ca
Breast Cancer Research 2008, 10:R86 doi:10.1186/bcr2156
Accesses
- Last 30 days: 156 accesses
- Last year: 1819 accesses
- All time: 8750 accesses
Cited by
BioMed Central: 4 citations
|
The Met oncogene and basal-like breast cancer: another culprit to watch out for? Stefania Gastaldi, Paolo M Comoglio, Livio Trusolino Breast Cancer Research 2010, 12:208 (23 August 2010) |
|
Edgar Dahl, Abdelaziz En-Nia, Frank Wiesmann, Renate Krings, Sonja Djudjaj, Elisabeth Breuer, Thomas Fuchs, Peter J Wild, Arndt Hartmann, Sandra E Dunn, Peter R Mertens BMC Cancer 2009, 9:410 (24 November 2009) |
|
Approaches towards expression profiling the response to treatment Andrew H Sims, John MS Bartlett Breast Cancer Research 2008, 10:115 (8 December 2008) |
|
Anna L Stratford, Christopher J Fry, Curtis Desilets, Alastair H Davies, Yong Y Cho, Yvonne Li, Zigang Dong, Isabelle M Berquin, Philippe P Roux, Sandra E Dunn Breast Cancer Research 2008, 10:R99 (27 November 2008) |